Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06537726

Breath Analysis for the Detection of Invasive Fungal Infections

Sponsor: University of Zurich

View on ClinicalTrials.gov

Summary

Patients with leukemia and concomitant neutropenia are at high risk of developing invasive fungal infections (IFI) that are associated with high morbidity and mortality. As these patients typically have severe thrombocytopenia, direct diagnostic sampling with invasive procedures is often not possible due to the high peri-interventional risk. Therefore, the presumptive diagnosis of IFI is primarily based on compatible lung findings on computed tomography and serologic detection of fungal cell wall components, which, however, have limited sensitivity and specificity. With the present study, the investigators aim to determine a set of specific volatile biomarkers in leukemia patients with proven or probable IFI using secondary electrospray ionization high-resolution mass spectrometry (SESI-HRMS).

Official title: Real-time Breath Analysis for the Detection of Invasive Fungal Infections in Neutropenic High-risk Patients

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

130

Start Date

2024-08-19

Completion Date

2027-10-31

Last Updated

2025-04-10

Healthy Volunteers

No

Interventions

DIAGNOSTIC_TEST

Secondary electrospray ionization high-resolution mass spectrometry (SESI-HRMS)

Identify volatile biomarkers of IFI by analyzing the breath metabolome of patients with proven or probable IFI according to the criteria outlined by EORTC/MSG and controls.

Locations (1)

University Hospital of Zurich

Zurich, Canton of Zurich, Switzerland